WHO ICTRP trial
A 12 weeks, randomized, double-blind, placebo-controlled human trial of Omija…
KCT0006613 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0006613 |
|---|---|
| Public title | A 12 weeks, randomized, double-blind, placebo-controlled human trial of Omija extract mixture on improvement of Hyperglycemia |
| Scientific title | A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Omija extract mixture on improvement of Hyperglycemia |
| Primary sponsor | Woosuk University Korean Medicine Medical Center |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Symptoms, signs and abnormal clinical and laboratory findings, NEC |
| Interventions | Dietary Supplement : • Omija extract mixture group: Twice a day, 2 capsules once, after breakfast and dinner, for 12 weeks(1.4 g/day, 0.5 g/day for Omija extract mixture) • Placebo group: Twice a day, 2 capsules once, after breakfast and… |
| Registration date | Sep 28, 2021 |
| Target size | 80 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: